{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:00:51Z","timestamp":1761512451252,"version":"3.33.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.yebeh.2007.06.005","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T11:21:58Z","timestamp":1189596118000},"page":"338-342","source":"Crossref","is-referenced-by-count":11,"title":["Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Ernest R.","family":"Somerville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel F.","family":"Berkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2007.06.005_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","article-title":"The epidemiology of epilepsy in Europe: a systematic review","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"issue":"Suppl 6","key":"10.1016\/j.yebeh.2007.06.005_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1528-1157.43.s.6.12.x","article-title":"The psychosocial burden of epilepsy","volume":"43","author":"Baker","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14737175.6.1.111","article-title":"Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors","volume":"6","author":"Schachter","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2007.06.005_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2007.06.005_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2007.06.005_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","article-title":"Adverse effects of antiepileptic drugs","volume":"181","author":"Perucca","year":"2005","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.yebeh.2007.06.005_bib8","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.yebeh.2007.06.005_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/35087000","article-title":"SV2 modulates the size of the readily releasable pool of secretory vesicles","volume":"3","author":"Xu","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.yebeh.2007.06.005_bib10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2007.06.005_bib12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2007.06.005_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0404.2006.00647.x","article-title":"Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial","volume":"113","author":"Genton","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2007.06.005_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.seizure.2006.05.013","article-title":"Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands","volume":"15","author":"Lambrechts","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.06.005_bib16","first-page":"1117","article-title":"Safety of levetiracetam as adjunctive therapy in epilepsy: the SKATE trial in Spain","volume":"38","author":"Salas-Puig","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.yebeh.2007.06.005_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2005.08.005","article-title":"Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland","volume":"14","author":"Steinhoff","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.06.005_bib18","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489\u2013501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"10.1016\/j.yebeh.2007.06.005_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1528-1157.1996.tb00612.x","article-title":"A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10","volume":"37","author":"Cramer","year":"1996","journal-title":"Epilepsia"},{"issue":"s8","key":"10.1016\/j.yebeh.2007.06.005_bib20","first-page":"348","article-title":"Adjunctive levetiracetam improves quality of life in line with patient priorities in epilepsy","volume":"43","author":"Cramer","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1684\/j.1950-6945.2006.tb00170.x","article-title":"Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience","volume":"8","author":"Leppik","year":"2006","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2007.06.005_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/seiz.2000.0407","article-title":"Efficacy of gabapentin as adjunctive therapy in a large, multicenter study","volume":"9","author":"Morrell","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.06.005_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-1331.2006.01381.x","article-title":"Assessment of a dose\u2013response relationship of levetiracetam","volume":"13","author":"Meencke","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2007.06.005_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1157.1984.tb03441.x","article-title":"Validation of the phenomenon of regression of seizure frequency in epilepsy","volume":"25","author":"Spilker","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.06.005_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.59.1.79","article-title":"Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?","volume":"59","author":"Somerville","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2007.06.005_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505007002235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505007002235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T23:34:33Z","timestamp":1737416073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505007002235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1525505007002235"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2007.06.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}